FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

Nature Genetics

Volumn 18, Issue 1, 1998, Pages 84-87

  Xiao, Sheng ^a   Nalabolu, Srinivasa R ^b   Aster, Jon C ^a   Ma, Junli ^c   Abruzzo, Lynne ^d   Jaffe, Elaine S ^e   Stone, Richard ^f   Weissman, Sherman M ^b   Hudson, Thomas J ^c   Fletcher, Jonathan A ^a,f,g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR;

ARTICLE; CELL INFILTRATION; CENTROMERE; CHROMOSOME TRANSLOCATION; DIMERIZATION; DNA HYBRIDIZATION; GENE EXPRESSION; GENE FUSION; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; LEUKEMIA; LYMPHOMA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 8; DNA-BINDING PROTEINS; HUMANS; LYMPHOMA, LYMPHOBLASTIC; MICE; MOLECULAR SEQUENCE DATA; MYELOPROLIFERATIVE DISORDERS; ONCOGENE PROTEINS, FUSION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; SYNDROME; TRANSLOCATION, GENETIC; ZINC FINGERS;

EID: 17344373285     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0198-84     Document Type: Article

References (30)

1. Rowley, J.D. Molecular cytogenetics: Rosetta stone for understanding cancer: twenty-ninth G.H.A. Clowes memorial award lecture. Cancer Res. 50, 3816-3825 (1990).
2. Rabbitts, T.H. Chromosomal translocations in human cancer. Nature 372, 143-149 (1994).
3. Offit, K. & Chaganti, R.S. Chromosomal aberrations in non-Hodgkin's lymphoma: biologic and clinical correlations. Hematol. Oncol. Clin. North Am. 5, 853-869 (1991).
4. Croce, CM. Molecular biology of lymphomas. Semin. Oncol. 20, 31-46 (1993).
5. Abruzzo, L.V. et al. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am. J. Surg. Pathol. 16, 236-245 (1992).
6. Inhorn, R.C. et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood 85, 1881-1887 (1995).
7. Fagan, K., Hyde, S. & Harrison, P. Translocation (8;13) and T-cell lymphoma: a case report. Cancer Genet. Cytogenet. 65, 71-73 (1993).
8. Naeem, R., Singer, S. & Fletcher, J.A. Translocation t(8;13)(p11;q11-12) in stem cell leukemia/lymphoma of T-cell and myeloid lineages. Genes Chromosom. Cancer 12, 148-151 (1995).
9. Macdonald, D., Aguiar, R.C., Mason, P.J., Goldman, J.M. & Cross, N.C. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia 9, 1628-1630 (1995).
10. Dib, A. et al. Characterization of the region of the short arm of chromosome 8 amplified in breast carcinoma. Oncogens 10, 995-1001 (1995).
11. Itoh, N., Terachi, T., Ohta, M. & Seo, M.K. The complete amino acid sequence of the shorter form of human basic fibroblast growth factor receptor deduced from its cDNA. Biochem. Biophys. Res. Commun. 169, 680-685 (1990).
12. van der Maarel, S.M. et al. Cloning and characterization of DXS6673E, a candidate gene for X-linked mental retardation in Xq13.1. Hum. Mol. Genet. 5, 887-897 (1996).
13. Verdier, A.S. et al. Chromosomal mapping of two novel human FGF genes, FGF11 and FGF12. Genomics 40, 151-154 (1996).
14. Burgess, W.H. & Maciag, T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58, 575-606 (1989).
15. Gabbianelli, M. et al. "Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science 249, 1561-1564 (1990).
16. Gabrilove, J.L., White, K., Rahman, Z. & Wilson, E.L. Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood 83, 907-910 (1994).
17. Wilson, E.L., Rifkin, D.B., Kelly, F., Hannocks, M.J. & Gabrilove, J.L. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 77, 954-960 (1991).
18. Avraham, H., Banu, N., Scadden, D.T., Abraham, J. & Groopman, J.E. Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood 83, 2126-2132 (1994).
19. Kouhara, H. et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89, 693-702 (1997).
20. Carroll, M., Tomasson, M.H., Barker, G.F., Golub, T.R. & Gilliland, D.G. The TEL/platelet-derived growth factor b receptor (PDGFbR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways. Proc. Natl. Acad. Sci. USA 93, 14845-14850 (1996).
21. Rodrigues, G.A. & Park, M. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol. Cell Biol. 13, 6711-6722 (1993).
22. Santoro, M. et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267, 381-383 (1995).
23. Tong, Q., Xing, S. & Jhiang, S.M. Leucine zipper-mediated dimerization is essential for the PTC1 oncogenic activity. J. Biol. Chem. 272, 9043-9047 (1997).
24. Luisi, B.F. et al. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352, 497-505 (1991).
25. Naski, M.C., Wang, Q., Xu, J. & Ornitz, D.M. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet. 13, 233-237 (1996).
26. Fletcher, J.A. et al. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N. Engl. J. Med. 324, 436-442 (1991).
27. Xiao, S., Renshaw, A.A., Cibas, E.S., Hudson, T.J. & Fletcher, J.A. Novel fluorescence in situ hybridization approaches in solid tumors: characterization of frozen specimens, touch preparations, and cytologic preparations. Am. J. Pathol. 147, 896-904 (1995).
28. Parimoo, S., Kolluri, R. & Weissman, S.M. cDNA selection from total yeast DNA containing YACs. Nucleic Acids Res. 21, 4422-4423 (1993).
29. Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396 (1993).
30. Aster, J.C. et al. Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-J or nuclear localization sequences retain the ability to associate with RBP-J and activate transcription. J. Biol. Chem. 272, 11336-11343 (1997).